Second re-irradiation: a narrative review of the available clinical data

References

• Nieder C, Langendijk JA, Guckenberger M, et al. Preserving the legacy of reirradiation: a narrative review of historical publications. Adv Radiat Oncol. 2017;2:176–182.
   PubMedGoogle Scholar
• Regaud C. Progress and limitation in the curative treatment of malignant neoplasms by radium. BJR. 1929;2:461–476.
   PubMedGoogle Scholar
• Kajanti MJ. Magnus Strandqvist: 50th anniversary of his doctoral thesis. Acta Oncol. 1994;33:735–738.
   PubMed Web of Science ®Google Scholar
• Robison RF. The race for megavoltage. X-rays versus telegamma. Acta Oncol. 1995;34:1055–1074.
   PubMed Web of Science ®Google Scholar
• Shack L, Lu S, Weeks LA, et al. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: a population level study. Radiother Oncol. 2017;122:152–158.
   PubMed Web of Science ®Google Scholar
• Seo YS, Kim MS, Kang JK, et al. The clinical utilization of radiation therapy in Korea between 2011 and 2015. Cancer Res Treat. 2017 [cited 2017 Apr 25]. DOI:10.4143/crt.2017.096
   Google Scholar
• Nieder C, Haukland E, Mannsåker B, et al. Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer. Oncol Lett. 2016;12:2930–2935.
   PubMed Web of Science ®Google Scholar
• Murphy WT, Schmitz A. The results of re-irradiation in cancer of the cervix. Radiology. 1956;67:378–385.
   PubMed Web of Science ®Google Scholar
• Shehata WM, Hendrickson FR, Hindo WA. Rapid fractionation technique and re-treatment of cerebral metastases by irradiation. Cancer. 1974;34:257–261.
   PubMed Web of Science ®Google Scholar
• Koffer P, Chan J, Rava P, et al. Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg. 2017;104:589–593.
   PubMed Web of Science ®Google Scholar
• Morales La Madrid A, Santa-María V, Cruz Martinez O, et al. Second re-irradiation for DIPG progression, re-considering “old strategies” with new approaches. Childs Nerv Syst. 2017;33:849–852.
   PubMed Web of Science ®Google Scholar
• Peulen H, Karlsson K, Lindberg K, et al. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol. 2011;101:260–266.
   PubMed Web of Science ®Google Scholar
• Feddock J, Cheek D, Steber C, et al. Re-irradiation using permanent interstitial brachytherapy (PIB): a potentially durable technique for salvaging recurrent pelvic malignancies. Int J Radiat Oncol Biol Phys. 2017;99:1225–1233.
   PubMed Web of Science ®Google Scholar
• Abusaris H, Storchi PR, Brandwijk RP, et al. Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields. Radiother Oncol. 2011;99:235–239.
   PubMed Web of Science ®Google Scholar
• Maenhout M, van Vulpen M, Moerland M, et al. Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer. J Contemp Brachyther. 2017;9:161–166.
   PubMed Web of Science ®Google Scholar
• Holly R, Morton GC, Sankreacha R, et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. Brachytherapy. 2011;10:299–305.
   PubMed Web of Science ®Google Scholar
• Thibault I, Campbell M, Tseng CL, et al. Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases. Int J Radiat Oncol Biol Phys. 2015;93:353–360.
   PubMed Web of Science ®Google Scholar
• Katsoulakis E, Riaz N, Cox B, et al. Delivering a third course of radiation to spine metastases using image-guided, intensity-modulated radiation therapy. J Neurosurg Spine. 2013;18:63–68.
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Igrutinovic I. Second single 4 Gy reirradiation for painful bone metastasis. J Pain Symptom Manage. 2002;23:26–30.
   PubMed Web of Science ®Google Scholar
• Healy WP. Carcinoma of cervix uteri. JAMA. 1931;97:1680–1683.
   Google Scholar
• Wang CC. To reirradiate or not to reirradiate? Int J Radiat Oncol Biol Phys. 1994;29:913.
   PubMed Web of Science ®Google Scholar
• Wong E, Hoskin P, Bedard G, et al. Re-irradiation for painful bone metastases – a systematic review. Radiother Oncol. 2014;110:61–70.
   PubMed Web of Science ®Google Scholar
• Chow E, van der Linden YM, Roos D, et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. 2014;15:164–171.
   PubMed Web of Science ®Google Scholar
• Masucci GL, Yu E, Ma L, et al. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev Anticancer Ther. 2011;11:1923–1933.
   PubMed Web of Science ®Google Scholar
• Grimm J, Sahgal A, Soltys SG, et al. Estimated risk level of unified stereotactic body radiation therapy dose tolerance limits for spinal cord. Semin Radiat Oncol. 2016;26:165–171.
   PubMed Web of Science ®Google Scholar
• Ang KK, Price RE, Stephens LC, et al. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys. 1993;25:459–464.
   PubMed Web of Science ®Google Scholar
• Ang KK, Jiang GL, Feng Y, et al. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001;50:1013–1020.
   PubMed Web of Science ®Google Scholar
• Stewart FA. Re-treatment after full-course radiotherapy: is it a viable option? Acta Oncol. 1999;38:855–862.
   PubMed Web of Science ®Google Scholar
• De Bari B, Filippi AR, Mazzola R, et al. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies. Cancer Treat Rev. 2015;41:511–518.
   PubMed Web of Science ®Google Scholar
• Drodge CS, Ghosh S, Fairchild A. Thoracic reirradiation for lung cancer: a literature review and practical guide. Ann Palliat Med. 2014;3:75–91.
   PubMedGoogle Scholar
• Guren MG, Undseth C, Rekstad BL, et al. Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol. 2014;113:151–157.
   PubMed Web of Science ®Google Scholar
• Nieder C, Langendijk JA, Guckenberger M, et al. Prospective randomized clinical studies involving reirradiation: lessons learned. Strahlenther Onkol. 2016;192:679–686.
   PubMed Web of Science ®Google Scholar
• Strojan P, Beitler JJ, Silver CE, et al. When is re-irradiation in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol. 2014;271:3107–3109.
   PubMed Web of Science ®Google Scholar
• Kessel KA, Hesse J, Straube C, et al. Validation of an established prognostic score after re-irradiation of recurrent glioma. Acta Oncol. 2017;56:422–426.
   PubMed Web of Science ®Google Scholar
• Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group protocol 9911. JCO. 2007;25:4800–4805.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Kasperts N, Leemans CR, et al. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol. 2006;78:306–312.
   PubMed Web of Science ®Google Scholar
• Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001;51:1299–1304.
   PubMed Web of Science ®Google Scholar
• Janot F, De Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26:5518–5523.
   PubMed Web of Science ®Google Scholar
• Tian YM, Zhao C, Guo Y, et al. Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial. Cancer. 2014;120:3502–3509.
   PubMed Web of Science ®Google Scholar
• Pulkkanen K, Lahtinen T, Lehtimäki A, et al. Effective palliation without normal tissue toxicity using low-dose ultrafractionated re-irradiation for tumor recurrence after radical or adjuvant radiotherapy. Acta Oncol. 2007;46:1037–1041.
   PubMed Web of Science ®Google Scholar
• Kooy HM, Grassberger C. Intensity modulated proton therapy. Br J Radiol. 2015;88:20150195.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631–640.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94:1073–1087.
   PubMed Web of Science ®Google Scholar